Form 4: ICU Medical Director Kolleen T. Kennedy Reports Stock Transactions
SEC Form 4 Filing
Director Kolleen T. Kennedy reports acquisition and disposal of ICU Medical Inc. stock, including restricted stock units, on May 15, 2024.
Summary
- On May 15, 2024, Kolleen T. Kennedy, a director of ICU Medical Inc., reported transactions involving the company's stock.
- Kennedy acquired 948 shares of common stock through the vesting of restricted stock units (RSUs).
- Kennedy also disposed of 1,562 shares of common stock.
- Additionally, Kennedy acquired 1,723 derivative securities in the form of restricted stock units, exercisable on May 15, 2025.
- The RSUs vest on the anniversary of the award date or the following annual stockholder meeting, whichever comes first.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions by a company director, with no inherent positive or negative implications.
Future Outlook
The restricted stock units vest on the anniversary of the date of the award or the following annual stockholder meeting, whichever occurs first.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- Shareholders are informed about the trading activities of a company director.
- The filing provides transparency regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/15/2024 | Date of stock transactions: acquisition of shares through RSU vesting, disposal of shares, and acquisition of new RSUs. |
| 05/15/2025 | Date when the acquired Restricted Stock Units become exercisable. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.